The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Compare brokers on index fund selections, focusing on fund variety, fees, and ease of use to pick the best platform for your needs.
28,035 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
The surge of higher rates and prices cooled real estate investors’ purchases to a six-year low. This article explains...
At a pivotal AI summit, the UN chief framed AI risks in a way that resonates with crypto stakeholders. This article t...
A growing share of Americans rely on pensions to anchor retirement. This piece breaks down how a $2,000 monthly pensi...
The UK debate over exempting overtime from income tax sounds like a simple win for workers, but the plan hides seriou...
Discover how seasoned landlords use simple systems behind 150-unit portfolios to free up time and grow wealth. This g...
AI is changing how and where we work, but the tools ahead disruption already exist to soften the impact. This report ...
A high-profile insider sale sparked questions about Bandwidth and its stock. This in-depth guide explains what bandwi...
Marcus Goldman Sachs Savings offers a no-fee, no-minimum online savings option with daily compounding. Here’s how it ...
New York City's education budget tops $42,000 per student in the 2027 proposal, the highest among large districts. Th...
A durable capex cycle is forming around upgrading the power grid to handle AI, EV charging, and reshoring needs. Anal...
SpaceX has entered another slide in its public debut era. This article breaks down what a second day of losses could ...